BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6595865)

  • 1. Immunoelectronmicroscopic demonstration of surface tumor antigen Ca 125.
    Blaustein A
    Ultrastruct Pathol; 1984; 7(1):9-11. PubMed ID: 6595865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors.
    Ghazizadeh M; Oguro T; Sasaki Y; Aihara K; Araki T; Springer GF
    Am J Clin Pathol; 1990 Mar; 93(3):315-21. PubMed ID: 1689937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer.
    Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI
    Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
    Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
    Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistological characterization of a monoclonal antibody (OV632) against epithelial ovarian carcinomas.
    Fleuren GJ; Coerkamp EG; Nap M; vd Broek LJ; Warnaar SO
    Virchows Arch A Pathol Anat Histopathol; 1987; 410(6):481-6. PubMed ID: 3105167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
    Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
    Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
    Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
    Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
    de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
    Huang JS
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas.
    Mettler L; Radzun HJ; Salmassi A; Köchling W; Parwaresch MR
    Cancer; 1990 Apr; 65(7):1525-32. PubMed ID: 2178766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructural characteristics of endometrioid and serous ovarian adenocarcinomas].
    Kolosov AE; Chernina LA; Bychkov VM
    Arkh Patol; 1983; 45(8):34-8. PubMed ID: 6639391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
    Friedman EL; Hayes DF; Kufe DW
    Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous tumors of the ovary: ultrastructural observations.
    Franchina M; Del Borrello E; Caruso A; Altavilla G
    Eur J Gynaecol Oncol; 1992; 13(3):268-76. PubMed ID: 1618226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterophile antigens in serous cystadenocarcinoma of the human ovary.
    Kamada M; Mori T; Sakamoto Y; Daitoh T; Furumoto H; Irahara M; Aono T; Mori T
    Asia Oceania J Obstet Gynaecol; 1992 Dec; 18(4):387-95. PubMed ID: 1283511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas.
    Masuho Y; Zalutsky M; Knapp RC; Bast RC
    Cancer Res; 1984 Jul; 44(7):2813-9. PubMed ID: 6202400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase.
    Shishi J; Ghazizadeh M; Oguro T; Aihara K; Araki T
    Am J Clin Pathol; 1986 May; 85(5):595-8. PubMed ID: 3518399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor-specific antigens in human mucinous cystadenocarcinoma of the ovary by immunodiffusion.
    Chow SN; Chiang WT; Wei PY
    Int J Gynaecol Obstet; 1976; 14(3):280-4. PubMed ID: 13019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.